这是ResMed全球睡眠调查的新发现，该调查还显示，42%的澳大利亚人起床时经常感到疲劳，这一比例在十几个国家中排名第二高。 超过50%的澳大利亚人 ...

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...

Update 03.16 PM EST: Adds comments from ResMed The U.S. Food and Drug Administration (FDA) on Thursday classified a product ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Investors need to buy shares before the ex-dividend date to gain access to that dividend. For Resmed, the shares will go ex-dividend on 8 May 2024, which is next Wednesday. That means investors ...

Sleep and respiratory disorders sector of the medical device industry ("Sleep and Respiratory Care') and the supply of business management software as a service to out-of-hospital health providers ...

ResMed's management isn't just brushing off the threat of weight loss drugs — it's doubling down on the theory that they'll benefit the company's sleep apnea business. 'We believe that the growth in ...

Across the recent three months, 6 analysts have shared their insights on ResMed RMD, expressing a variety of opinions spanning from bullish to bearish. The following table provides a quick ...

5-Year U.S. Treasury Note Continuous Contract $110.414-0.164-0.15% 10-Year U.S. Treasury Note Continuous Contract $115.094-0.281-0.24% ...

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

The ASX finished higher on Friday after a choppy start to trading, with investors taking a shine to higher commodity prices.

The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Please note that the dividend history for Nasdaq stocks ...